1 Study Coverage
1.1 Cobamamide for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Cobamamide for Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.5mg
1.2.3 1.0mg
1.2.4 1.5mg
1.3 Market by Application
1.3.1 Global Cobamamide for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cobamamide for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Cobamamide for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Cobamamide for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cobamamide for Injection Sales by Region
2.4.1 Global Cobamamide for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Cobamamide for Injection by Region (2023-2028)
2.5 Global Cobamamide for Injection Revenue by Region
2.5.1 Global Cobamamide for Injection Revenue by Region (2017-2022)
2.5.2 Global Cobamamide for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cobamamide for Injection Sales by Manufacturers
3.1.1 Global Top Cobamamide for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Cobamamide for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cobamamide for Injection in 2021
3.2 Global Cobamamide for Injection Revenue by Manufacturers
3.2.1 Global Cobamamide for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Cobamamide for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cobamamide for Injection Revenue in 2021
3.3 Global Cobamamide for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cobamamide for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cobamamide for Injection Sales by Type
4.1.1 Global Cobamamide for Injection Historical Sales by Type (2017-2022)
4.1.2 Global Cobamamide for Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Cobamamide for Injection Sales Market Share by Type (2017-2028)
4.2 Global Cobamamide for Injection Revenue by Type
4.2.1 Global Cobamamide for Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Cobamamide for Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cobamamide for Injection Revenue Market Share by Type (2017-2028)
4.3 Global Cobamamide for Injection Price by Type
4.3.1 Global Cobamamide for Injection Price by Type (2017-2022)
4.3.2 Global Cobamamide for Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cobamamide for Injection Sales by Application
5.1.1 Global Cobamamide for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Cobamamide for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Cobamamide for Injection Sales Market Share by Application (2017-2028)
5.2 Global Cobamamide for Injection Revenue by Application
5.2.1 Global Cobamamide for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Cobamamide for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cobamamide for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Cobamamide for Injection Price by Application
5.3.1 Global Cobamamide for Injection Price by Application (2017-2022)
5.3.2 Global Cobamamide for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cobamamide for Injection Market Size by Type
6.1.1 North America Cobamamide for Injection Sales by Type (2017-2028)
6.1.2 North America Cobamamide for Injection Revenue by Type (2017-2028)
6.2 North America Cobamamide for Injection Market Size by Application
6.2.1 North America Cobamamide for Injection Sales by Application (2017-2028)
6.2.2 North America Cobamamide for Injection Revenue by Application (2017-2028)
6.3 North America Cobamamide for Injection Market Size by Country
6.3.1 North America Cobamamide for Injection Sales by Country (2017-2028)
6.3.2 North America Cobamamide for Injection Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cobamamide for Injection Market Size by Type
7.1.1 Europe Cobamamide for Injection Sales by Type (2017-2028)
7.1.2 Europe Cobamamide for Injection Revenue by Type (2017-2028)
7.2 Europe Cobamamide for Injection Market Size by Application
7.2.1 Europe Cobamamide for Injection Sales by Application (2017-2028)
7.2.2 Europe Cobamamide for Injection Revenue by Application (2017-2028)
7.3 Europe Cobamamide for Injection Market Size by Country
7.3.1 Europe Cobamamide for Injection Sales by Country (2017-2028)
7.3.2 Europe Cobamamide for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cobamamide for Injection Market Size by Type
8.1.1 Asia Pacific Cobamamide for Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Cobamamide for Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Cobamamide for Injection Market Size by Application
8.2.1 Asia Pacific Cobamamide for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Cobamamide for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Cobamamide for Injection Market Size by Region
8.3.1 Asia Pacific Cobamamide for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Cobamamide for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cobamamide for Injection Market Size by Type
9.1.1 Latin America Cobamamide for Injection Sales by Type (2017-2028)
9.1.2 Latin America Cobamamide for Injection Revenue by Type (2017-2028)
9.2 Latin America Cobamamide for Injection Market Size by Application
9.2.1 Latin America Cobamamide for Injection Sales by Application (2017-2028)
9.2.2 Latin America Cobamamide for Injection Revenue by Application (2017-2028)
9.3 Latin America Cobamamide for Injection Market Size by Country
9.3.1 Latin America Cobamamide for Injection Sales by Country (2017-2028)
9.3.2 Latin America Cobamamide for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cobamamide for Injection Market Size by Type
10.1.1 Middle East and Africa Cobamamide for Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cobamamide for Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Cobamamide for Injection Market Size by Application
10.2.1 Middle East and Africa Cobamamide for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cobamamide for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Cobamamide for Injection Market Size by Country
10.3.1 Middle East and Africa Cobamamide for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cobamamide for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Haerbin Medisan
11.1.1 Haerbin Medisan Corporation Information
11.1.2 Haerbin Medisan Overview
11.1.3 Haerbin Medisan Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Haerbin Medisan Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Haerbin Medisan Recent Developments
11.2 North China Pharmaceutical Group
11.2.1 North China Pharmaceutical Group Corporation Information
11.2.2 North China Pharmaceutical Group Overview
11.2.3 North China Pharmaceutical Group Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 North China Pharmaceutical Group Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 North China Pharmaceutical Group Recent Developments
11.3 Chongqing Yaoyou Pharmaceutical
11.3.1 Chongqing Yaoyou Pharmaceutical Corporation Information
11.3.2 Chongqing Yaoyou Pharmaceutical Overview
11.3.3 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chongqing Yaoyou Pharmaceutical Recent Developments
11.4 Hainan Star Pharmaceutical
11.4.1 Hainan Star Pharmaceutical Corporation Information
11.4.2 Hainan Star Pharmaceutical Overview
11.4.3 Hainan Star Pharmaceutical Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Hainan Star Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hainan Star Pharmaceutical Recent Developments
11.5 Hebei Zhitong Biopharmaceutical
11.5.1 Hebei Zhitong Biopharmaceutical Corporation Information
11.5.2 Hebei Zhitong Biopharmaceutical Overview
11.5.3 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
11.6 Jiangsu Jiuxu Pharmaceutical
11.6.1 Jiangsu Jiuxu Pharmaceutical Corporation Information
11.6.2 Jiangsu Jiuxu Pharmaceutical Overview
11.6.3 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Jiangsu Jiuxu Pharmaceutical Recent Developments
11.7 Jiuquan Dadeli pharmaceutical
11.7.1 Jiuquan Dadeli pharmaceutical Corporation Information
11.7.2 Jiuquan Dadeli pharmaceutical Overview
11.7.3 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiuquan Dadeli pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cobamamide for Injection Industry Chain Analysis
12.2 Cobamamide for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cobamamide for Injection Production Mode & Process
12.4 Cobamamide for Injection Sales and Marketing
12.4.1 Cobamamide for Injection Sales Channels
12.4.2 Cobamamide for Injection Distributors
12.5 Cobamamide for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cobamamide for Injection Industry Trends
13.2 Cobamamide for Injection Market Drivers
13.3 Cobamamide for Injection Market Challenges
13.4 Cobamamide for Injection Market Restraints
14 Key Findings in The Global Cobamamide for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cobamamide for Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 0.5mg
Table 3. Major Manufacturers of 1.0mg
Table 4. Major Manufacturers of 1.5mg
Table 5. Global Cobamamide for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Cobamamide for Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cobamamide for Injection Sales by Region (2017-2022) & (Kg)
Table 8. Global Cobamamide for Injection Sales Market Share by Region (2017-2022)
Table 9. Global Cobamamide for Injection Sales by Region (2023-2028) & (Kg)
Table 10. Global Cobamamide for Injection Sales Market Share by Region (2023-2028)
Table 11. Global Cobamamide for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Cobamamide for Injection Revenue Market Share by Region (2017-2022)
Table 13. Global Cobamamide for Injection Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Cobamamide for Injection Revenue Market Share by Region (2023-2028)
Table 15. Global Cobamamide for Injection Sales by Manufacturers (2017-2022) & (Kg)
Table 16. Global Cobamamide for Injection Sales Share by Manufacturers (2017-2022)
Table 17. Global Cobamamide for Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Cobamamide for Injection Revenue Share by Manufacturers (2017-2022)
Table 19. Cobamamide for Injection Price by Manufacturers (2017-2022) &(US$/g)
Table 20. Global Cobamamide for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Cobamamide for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cobamamide for Injection as of 2021)
Table 22. Cobamamide for Injection Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Cobamamide for Injection Product Offered
Table 24. Date of Manufacturers Enter into Cobamamide for Injection Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 27. Global Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 28. Global Cobamamide for Injection Sales Share by Type (2017-2022)
Table 29. Global Cobamamide for Injection Sales Share by Type (2023-2028)
Table 30. Global Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Cobamamide for Injection Revenue Share by Type (2017-2022)
Table 33. Global Cobamamide for Injection Revenue Share by Type (2023-2028)
Table 34. Cobamamide for Injection Price by Type (2017-2022) & (US$/g)
Table 35. Global Cobamamide for Injection Price Forecast by Type (2023-2028) & (US$/g)
Table 36. Global Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 37. Global Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 38. Global Cobamamide for Injection Sales Share by Application (2017-2022)
Table 39. Global Cobamamide for Injection Sales Share by Application (2023-2028)
Table 40. Global Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Cobamamide for Injection Revenue Share by Application (2017-2022)
Table 43. Global Cobamamide for Injection Revenue Share by Application (2023-2028)
Table 44. Cobamamide for Injection Price by Application (2017-2022) & (US$/g)
Table 45. Global Cobamamide for Injection Price Forecast by Application (2023-2028) & (US$/g)
Table 46. North America Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 47. North America Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 48. North America Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 51. North America Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 52. North America Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 55. North America Cobamamide for Injection Sales by Country (2023-2028) & (Kg)
Table 56. North America Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Cobamamide for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 59. Europe Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 60. Europe Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 63. Europe Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 64. Europe Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 67. Europe Cobamamide for Injection Sales by Country (2023-2028) & (Kg)
Table 68. Europe Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Cobamamide for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 71. Asia Pacific Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 72. Asia Pacific Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 75. Asia Pacific Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 76. Asia Pacific Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Cobamamide for Injection Sales by Region (2017-2022) & (Kg)
Table 79. Asia Pacific Cobamamide for Injection Sales by Region (2023-2028) & (Kg)
Table 80. Asia Pacific Cobamamide for Injection Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Cobamamide for Injection Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 83. Latin America Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 84. Latin America Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 87. Latin America Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 88. Latin America Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 91. Latin America Cobamamide for Injection Sales by Country (2023-2028) & (Kg)
Table 92. Latin America Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Cobamamide for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Cobamamide for Injection Sales by Type (2017-2022) & (Kg)
Table 95. Middle East and Africa Cobamamide for Injection Sales by Type (2023-2028) & (Kg)
Table 96. Middle East and Africa Cobamamide for Injection Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Cobamamide for Injection Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Cobamamide for Injection Sales by Application (2017-2022) & (Kg)
Table 99. Middle East and Africa Cobamamide for Injection Sales by Application (2023-2028) & (Kg)
Table 100. Middle East and Africa Cobamamide for Injection Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Cobamamide for Injection Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Cobamamide for Injection Sales by Country (2017-2022) & (Kg)
Table 103. Middle East and Africa Cobamamide for Injection Sales by Country (2023-2028) & (Kg)
Table 104. Middle East and Africa Cobamamide for Injection Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Cobamamide for Injection Revenue by Country (2023-2028) & (US$ Million)
Table 106. Haerbin Medisan Corporation Information
Table 107. Haerbin Medisan Description and Major Businesses
Table 108. Haerbin Medisan Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 109. Haerbin Medisan Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Haerbin Medisan Recent Developments
Table 111. North China Pharmaceutical Group Corporation Information
Table 112. North China Pharmaceutical Group Description and Major Businesses
Table 113. North China Pharmaceutical Group Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 114. North China Pharmaceutical Group Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. North China Pharmaceutical Group Recent Developments
Table 116. Chongqing Yaoyou Pharmaceutical Corporation Information
Table 117. Chongqing Yaoyou Pharmaceutical Description and Major Businesses
Table 118. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 119. Chongqing Yaoyou Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Chongqing Yaoyou Pharmaceutical Recent Developments
Table 121. Hainan Star Pharmaceutical Corporation Information
Table 122. Hainan Star Pharmaceutical Description and Major Businesses
Table 123. Hainan Star Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 124. Hainan Star Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Hainan Star Pharmaceutical Recent Developments
Table 126. Hebei Zhitong Biopharmaceutical Corporation Information
Table 127. Hebei Zhitong Biopharmaceutical Description and Major Businesses
Table 128. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 129. Hebei Zhitong Biopharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Hebei Zhitong Biopharmaceutical Recent Developments
Table 131. Jiangsu Jiuxu Pharmaceutical Corporation Information
Table 132. Jiangsu Jiuxu Pharmaceutical Description and Major Businesses
Table 133. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 134. Jiangsu Jiuxu Pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Jiangsu Jiuxu Pharmaceutical Recent Developments
Table 136. Jiuquan Dadeli pharmaceutical Corporation Information
Table 137. Jiuquan Dadeli pharmaceutical Description and Major Businesses
Table 138. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2017-2022)
Table 139. Jiuquan Dadeli pharmaceutical Cobamamide for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Jiuquan Dadeli pharmaceutical Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Cobamamide for Injection Distributors List
Table 144. Cobamamide for Injection Customers List
Table 145. Cobamamide for Injection Market Trends
Table 146. Cobamamide for Injection Market Drivers
Table 147. Cobamamide for Injection Market Challenges
Table 148. Cobamamide for Injection Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Cobamamide for Injection Product Picture
Figure 3. Global Cobamamide for Injection Market Share by Type in 2021 & 2028
Figure 3. 0.5mg Product Picture
Figure 4. 1.0mg Product Picture
Figure 5. 1.5mg Product Picture
Figure 6. Global Cobamamide for Injection Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Drug Store
Figure 9. Other
Figure 10. Cobamamide for Injection Report Years Considered
Figure 11. Global Cobamamide for Injection Sales 2017-2028 (Kg)
Figure 12. Global Cobamamide for Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Cobamamide for Injection Revenue 2017-2028 (US$ Million)
Figure 14. Global Cobamamide for Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Cobamamide for Injection Sales Market Share by Region (2017-2022)
Figure 16. Global Cobamamide for Injection Sales Market Share by Region (2023-2028)
Figure 17. North America Cobamamide for Injection Sales YoY (2017-2028) & (Kg)
Figure 18. North America Cobamamide for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Cobamamide for Injection Sales YoY (2017-2028) & (Kg)
Figure 20. Europe Cobamamide for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Cobamamide for Injection Sales YoY (2017-2028) & (Kg)
Figure 22. Asia-Pacific Cobamamide for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Cobamamide for Injection Sales YoY (2017-2028) & (Kg)
Figure 24. Latin America Cobamamide for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Cobamamide for Injection Sales YoY (2017-2028) & (Kg)
Figure 26. Middle East & Africa Cobamamide for Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Cobamamide for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Cobamamide for Injection in the World: Market Share by Cobamamide for Injection Revenue in 2021
Figure 29. Global Cobamamide for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 31. Global Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 32. Global Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 33. Global Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 34. North America Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 35. North America Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 36. North America Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 37. North America Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 38. North America Cobamamide for Injection Sales Share by Country (2017-2028)
Figure 39. North America Cobamamide for Injection Revenue Share by Country (2017-2028)
Figure 40. U.S. Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 43. Europe Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 44. Europe Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 45. Europe Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 46. Europe Cobamamide for Injection Sales Share by Country (2017-2028)
Figure 47. Europe Cobamamide for Injection Revenue Share by Country (2017-2028)
Figure 48. Germany Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 49. France Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Cobamamide for Injection Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Cobamamide for Injection Revenue Share by Region (2017-2028)
Figure 59. China Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 62. India Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 70. Latin America Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 72. Latin America Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Cobamamide for Injection Sales Share by Country (2017-2028)
Figure 74. Latin America Cobamamide for Injection Revenue Share by Country (2017-2028)
Figure 75. Mexico Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Cobamamide for Injection Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Cobamamide for Injection Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Cobamamide for Injection Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Cobamamide for Injection Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Cobamamide for Injection Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Cobamamide for Injection Revenue Share by Country (2017-2028)
Figure 84. Turkey Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Cobamamide for Injection Revenue (2017-2028) & (US$ Million)
Figure 87. Cobamamide for Injection Value Chain
Figure 88. Cobamamide for Injection Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
